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436Juxta-anastomotic stenting with aggressive
angioplasty will salvage the native radiocephalic
ﬁstula for dialysis
John Swinnen, MBChB, FRACS (General), FRACS (Vascular), DDU (Vascular),a Kia Lean Tan, CSAMM,a
Richard Allen, FRACS,a David Burgess, FRACP,b and Irwin V. Mohan, FRCS, RACS,a Sydney, New South
Wales, Australia
Objective: This study describes our technique of aggressive angioplasty with juxta-anastomotic stenting (JXAS) in the
autogenous arteriovenous ﬁstula and reviews our outcomes with this technique in its mature form.
Methods:We developed a JXAS technique during the last 7 years. Since 2006, we have placed 135 JXASs. The study period
reviews 68 consecutive JXASs placed from 2008 to 2012 using the mature technique. We retrospectively analyzed the
prospectively collected data. Thirty-three ﬁstulas received JXAS for failure to mature, and 35 were mature but inade-
quately dialyzing ﬁstulas (problem ﬁstulas). The JXAS technique involves (1) treating the JXA segment as a unit, (2)
aggressive angioplasty with rupture of stenoses, and (3) placement of an uncovered nitinol stent.
Results: Technical success was 97%. Of the ﬁstulas that had failed to mature, 75% were brought to maturity by 6 months
and 88% by 12 months. Adequate dialysis was achieved in all 35 problem ﬁstulas immediately postoperatively. Assisted
ﬁstula patency was 90% at 2 years and 80% at 4 years.
Conclusions: JXAS is an effective technique for maturing and maintaining the wrist radiocephalic arteriovenous
ﬁstula. (J Vasc Surg 2015;61:436-42.)The autogenous arteriovenous ﬁstula (AVF) is the
optimum method of hemodialysis access in end-stage
renal failure. The best AVF conﬁguration is the distal
radiocephalic (RC) AVF, with the best patency and
lowest reintervention rates compared with alternative
access types.1-4
Access failure from venous stenoses is the commonest
problem, occurring in up to 78% of cases.5,6 Fistulas that
fail to mature (FTM) are AVFs that never develop to the
point of dialysis, many of which are traditionally abandoned.
Problem ﬁstulas (PFs) are mature ﬁstulas experiencing dial-
ysis difﬁculties. These FTM ﬁstulas and PFs frequently have
a stenosis in the circuit. The commonest site for stenosis is
the juxta-anastomotic (JXA) segment: the distal radial ar-
tery, the anastomosis, and the “swing vein” (Fig 1). Falk
et al7 described the “swing point” as the surgical site of
vein mobilization that is generally at, or#5 cm of the anas-
tomosis, and a common cause of ﬁstula failure.
In the JXA segment, swing vein stenoses are the
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Badero et al8 found that the swing vein accounted for
45.7% of all stenosis and that the JXA segment accounted
for 63% of all lesions. The reason the JXA segment is a
frequent site of stenotic lesions is unclear, but the the swing
vein is the segment that is surgically dissected and possibly
devascularized or twisted during the creation of the AVF.9
Conventional management strategies for JXA stenoses
are all problematic.1,2,7 Proximalization of the RC AVF is
often used to treat problems in the JXA segment. Howev-
er, this reduces the useable length of the ﬁstula, and similar
JXA problems often develop at the site of proximalization.
Proximal revision to the brachiocephalic or brachiobasilic
level produces a ﬁstula with higher complication rates
such as arterial steal and high output states. Suggestions
have been made that salvage of the failing native AVF is
not worth the effort and that the patient should be
converted to an AV graft; however, primary patency of
AV grafts may be as low as 60% at 1 year, and infective
complications are common.6,10,11 Finally, conventional
angioplasty of the JXA stenoses has variable success and
high recurrence rates.12,13 Studies report up to one-third
of ﬁstulas fail to show increased blood ﬂow after successful
angioplasty.14
During the last 15 years, we have developed aggressive
endovascular techniques for treating AVF stenoses,
including routine rupture of stenoses and frequent use of
uncovered nitinol stents. We applied these techniques to
the JXA segment, and now treat most JXA problems
with JXA stenting (JXAS). We use JXAS in FTM ﬁstulas
for balloon-assisted maturation and also in PFs to
re-establish adequate dialysis. In this report, we review
our experience with JXAS in the native RC AVF.
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The study period was 4.5 years, from January 2008
to June 2012. The JXA segment is illustrated in Fig 1
and includes the anastomosis, the last 62 cm of the
radial artery, and 65 cm of the swing vein. All JXASs
placed or attempted in this period are included. JXAS
is a more difﬁcult endovascular ﬁstula intervention, and
we experienced a considerable learning curve developing
this technique. We placed our ﬁrst JXAS in 2006. The
present study reviews our technique in its mature form,
as used since January 2008. All data were collected pro-
spectively. Follow-up was by 3-month duplex ultrasound
and clinical review. The research was approved by the
Ethics Committee.
Indications
JXAS was used in FTM ﬁstulas and in PF with signiﬁ-
cant JXA stenoses on ultrasound imaging. We used JXAS
instead of other endovascular interventions when there
was >1 JXA stenosis, recurrent JXA stenosis, or a single
stenosis #1 cm of the anastomosis (to avoid crushing the
radial artery). All ﬁstulas with JXA segment stenoses
meeting these criteria were scheduled for JXAS and are
included in the study. The study deﬁned a signiﬁcant ste-
nosis as a ﬂow channel on duplex scan <2.7 mm in diam-
eter, as previously deﬁned by our group.15,16
Technique
Workup. All procedures are preceded by a duplex
scan, using a high-frequency probe (17-5MHz), to estab-
lish the site, length, and severity of the stenoses, the ade-
quacy of the ﬁstula outﬂow, the ﬁstula inﬂow in the afferent
and efferent artery, and the endovascular approach to be
used, and to determine the urgency of intervention. The
JXAS is performed as a day case, local anesthetic procedure,
some with sedation. Predialysis patients are prehydrated. All
procedures are performed with half-strength contrast. The
dialysis in patients already dialyzing through their ﬁstula is
usually not disrupted. Occasionally, if there is signiﬁcant arm
swelling, we will elevate the arm overnight and delay dialysis
by 24 hours.
Access and imaging. Access to theﬁstula circuit is retro-
grade, through the venous side of the ﬁstula, using a 6F
bright-tip sheath (Fig 2), staying >1 cm clear of the cephalic
landing zone (Fig 1, f). In the PF, we access the JXA through
the useable segment; in the FTM ﬁstula, we try to access
through one of the outﬂow veins in the arm (cephalic or
basilic) to avoid obstructing the immature ﬁstula’s outﬂow.
First, antegrade imaging is performed of the outﬂow to
conﬁrm unobstructed access to the right atrium. Second,
retrograde imaging of the JXA segment is performed
through the sheath, with the venous outﬂow obstructed.
Finally, access “around-the-corner” is obtained (Fig 2).
This allows antegrade imaging, and placement of the JXAS.
With experience, going “around-the-corner” is possible in
>95% of cases. A 300-cm Bentson wire (Cook Medical,
Bloomington, Ind) is the working wire.Angioplasty. A scouting predilatation of the JXA area
is performed, with a 3- to 4-mm balloon of appropriate
length (Fig 1). This allows subsequent antegrade imaging if
the traversed stenoses are very tight, and gives a feel for the
tightness of the stenoses and an estimate of the length of
the JXAS needed. High-pressure or cutting balloons may
be necessary. A second 5- to 6-mm predilatation is per-
formed of the perianastomotic site (Fig 1) to make room
for stent deployment and aggressive in-stent postdilatation.
Stenting. Once the JXA area has been adequately pre-
pared with predilatation, a JXAS is placed. Uncovered
nitinol stents are always used. They allow for re-
endothelialization, leave no signiﬁcant foreign body that
can lead to sepsis, and are resistant to crushing.
Stent diameter. The stent diameter needs to match the
inﬂow artery as well as the outﬂow vein. The healthy part of
the inﬂow artery is often w3 mm in diameter, and the
outﬂow part of the stent may lie within the useable
segment, at $6 mm (“Rule of 6’s”5). In practice, nitinol
stents are very forgiving to diameter mismatch, and we
have found that a 6-mm stent works best.
Stent length. Initially, we used shorter stents, 40 to
60 mm, conﬁning the stent to the stenotic area of the JXA
segment treated. We found, however, that the nitinol stent,
cut from a straight nitinol tube, would straighten over time
and kink at the junction with the healthy radial artery. We
had also noted the stent eroding through the skin overlying
the swing vein. Therefore, we now use long stents, 60 to
100 mm, and we have not seen any of the straightening
problems associated with the shorter stents.
Stent type. The stent and stent delivery device needs to
be ﬂexible to negotiate the often acute JXA angle, and the
stent itself needs to be kink resistant. Our experience is with
the SMART stent (Cordis Corp, Bridgewater, NJ), the Life-
Stent (BardPeripheral Vascular, Inc,Tempe,Ariz), andmore
recently, we have used the SUPERA stent (IDEV Technolo-
gies Inc, Webster, Tex), with its very high kink resistance.
Stent deployment. The JXA stent is deployed, ﬁrst, in
the distal radial artery, where it is of adequate caliber (the
radial artery landing zone), then around the corner, and
ﬁnally, into a segment of the ﬁstula vein that is of adequate
calibre (the cephalic vein landing zone; Fig 1). All the
stenotic segmentsdradial, anastomotic, or swing veind
should now lie between these two landing zones and
should be covered by the stent.
The stent may also be stretched to some extent to reach
to the desired cephalic vein landing zone, but a second ce-
phalic vein stent can be readily deployed within the JXAS
if the venous end of the stent lands short. We have found
that deploying a second radial artery stent if we had not
gone far enough into the radial artery is muchmore difﬁcult!
Postdilatation is done completely within the stent
(Fig 1). Passing the postdilation balloon around the corner
may be difﬁcult because of the acute angle and because of
the “ﬁsh-scaling” of the stent struts. A push-pull technique
will help to get the balloon around. The importance of
adequate predilatation to open up the anastomotic angle
and stenoses must be emphasized.
Fig 1. The juxta-anastomotic (JXA) segment and the steps in JXA stenting (JXAS). a, JXA stenosis; b, scouting
balloon angioplasty; c, predilatation; d, JXAS; e, postdilatation; f, completion.
Fig 2. Technique for going “around-the-corner.” Step 1: Perform
retrograde imaging of the juxta-anastomotic (JXA) segment
through the sheath (with occlusion of the outﬂow), to get a road
map for negotiating “around-the-corner” and visualize the ste-
noses. Step 2: Pass an angled hydrophilic wire and 4F hydrophilic
catheter with a torque device into the radial artery.
JOURNAL OF VASCULAR SURGERY
438 Swinnen et al February 2015Within the conﬁnes of the stent, aggressive angioplasty
with ﬁstula rupture is performed, including the perianasto-
motic radial artery. Normally, a signiﬁcant size discrepancy
exists between the distal radial artery (2-4 mm) and the
healthy ﬁstula vein (5-7 mm, the cephalic vein landing
zone; Fig 1). In practice, we use a 6-mm stent, which is a
good compromise between the sizes. We dilate the venous
part of the JXAS up to 6 mm (because rupture is very safe
here); the distal radial artery and anastomotic portion of the
stent are dilated a bit more cautiously, certainly up to 4 mm
and usually up to 5 mm. This is based on our research,15
which shows that a ﬁstula needs a minimum inﬂow diameter
of 2.7mmto function adequately. In anticipationof somede-
gree of recoil and healing, we therefore try to achieve aminimum JXAS diameter of 4 or 5 mm. Note that the post-
dilation balloon must stay clear of the stented radial artery
landing zone by >1 cm (Fig 1), because a disruption of the
stented/unstented radial artery junctionwill block theﬁstula.
Completion. Angiography and stitch closure of access
site17 (Fig 3).RESULTS
Numbers
We placed our ﬁrst JXAS in 2006 and have placed 145
JXASs since. The study period covers the 68 consecutive
JXAS procedures attempted between January 2008 and
June 2012 in 68 ﬁstulas in 68 patients.
Demographics
Patients were aged 58 years (range, 18-82 years), with
48 men and 20 women. Age of AVF since creation was
18 months (range, 2 days-8.5 years). There were 33
FTM ﬁstulas and 35 PFs. Interventions to the JXA segment
before JXAS are shown in Fig 4. Zones of JXA segment ste-
nosed are described in Table I.
Technical aspects
Stents per procedure. One stent was used in 60 pa-
tients, and two stentswere used in eight. Average stent length
was 60mm (range, 20-140mm) in the ﬁrst half of the series,
and 105 mm (60-230 mm) in the second half of the series.
Stent diameters were 5 mm and 6 mm. Stents used were
the SMART stent in 28, LifeStent in 27, Absolute (Abbott
Vascular,AbbottPark, Ill) in6,Precise (Cordis,MiamiLakes,
Fla) in 2, the SUPERA stent in 2, other stents in 2.
Technical success rate. Sixty-six JXASs were success-
fully placed in 68 patients (97%). Both technical failures
Fig 3. The juxta-anastomotic (JXA) stenting (JXAS) sequence.
Fig 4. Interventions before juxta-anastomotic (JXA) stenting (JXAS).
Table I. Number of stenosed zones of the juxta-anastomotic (JXA) segment
Zone Swing vein, No. Radial artery distal, No. Anastomosis, No. Total, No.
1 only 23 4 1 28
2 19 19 6 31
3 9 9 9 9
Total 57 38 22
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Fig 5. Stent-assisted maturation.
Fig 6. Kaplan-Meier curves show patency for ﬁstula and juxta-
anastomotic stenting (JXAS).
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the corner.
Stent-assisted maturation. Of the 33 ﬁstulas that
received JXAS for FTM, there was one technical failure
where we were unable to complete the procedure (Fig 5).
Twenty-ﬁve of the 32 patients were dialyzing through their
ﬁstula at 6 months (76% maturation at 6 months), and 29
were dialyzing at 1 year (91% maturation at 1 year).
Patency of the ﬁstula circuit and patency of JXAS
Fig 6 shows the Kaplan-Meier curves for follow-up of
the study cohort at 6 to 48 months. Fistula patency refers
to the patency of the ﬁstula, including assisted patency;
JXAS patency refers to the patency of the JXAS, including
assisted patency of the JXAS, with ﬁstula failures due to
non-JXAS problems censored. The censored interventions
are those where the JXAS is shown to be well patent on ul-
trasound imaging or ﬁstulogram, or both, but a signiﬁcant
problem is identiﬁed in a nonadjacent part of the circuit
that requires intervention. Fistula primary patency refers
to primary patency of the ﬁstula circuit. JXAS primary
patency refers to primary patency of the JXAS, with assisted
primary patency due to non-JXAS included.
Reintervention rates and assisted patency. Table II
summarizes ﬁstula reinterventions after placement of the
JXAS. All reinterventions except one were endovascular
procedures. Reinterventions are broken down into those
done because of recurrent problems in the JXA segment as
opposed to reinterventions because of problems elsewhere
in the ﬁstula circuit.
Complications
No signiﬁcant complications occurred in the study
group. Rupture of the JXA segment caused minor wristswelling in most patients, but there were no uncontrolled
ruptures. There were no open conversions, and no covered
stents were used.
DISCUSSION
AV grafts are used for dialysis in a signiﬁcant propor-
tion of patients in the United States. These grafts
commonly develop venous outﬂow stenoses requiring
some form of reintervention to maintain patency, and re-
sults of conventional angioplasty may result in patency as
low as 10% at 1 year.18,19
Vascular access for hemodialysis has evolved in our unit
during the last 15 years in several ways. We use a long-term
tunnelled catheter for primary vascular acces in patients
with a limited life expectancy (<6 to 18 months) and
when native ﬁstula creation is deemed difﬁcult. In all other
patients, we use a native ﬁstula. Initially, this was a “ﬁstula
Table II. Reinterventions after juxta-anastomotic stenting (JXAS)
Time of follow-up
after JXAS, months
Fistulas at risk of
reoperation, No.
Fistulas reoperated on in
preceding 6 months, No. (%)
Fistulas reoperated on
for JXAS, No. (%)
Fistulas reoperated on for
other reasons, No. (%)
Open revision,
No.
6 64 8 (12) 4 (6) 4 (6) 1
12 51 20 (40) 18 (35) 2 (4) 0
18 33 10 (30) 7 (5) 3 (1) 0
24 24 6 (25) 4 (17) 2 (8) 0
30 14 7 (50) 6 (43) 1 (7) 0
36 8 1 (12.5) 0 (0) 1 (12.5) 0
42 8 1 (12.5) 1 (12.5) 1 0
48 6 1 (17) 0 (0) 1 (17) 0
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only” policy. Because the distal RC AVF is the best conﬁg-
uration,1-4 we create a distal RC AVF in more than half of
our access patients.
The challenge of creating distal ﬁstulas is com-
pounded by an older patient population with more
damaged arteries and veins. Diabetes, in particular, is
becoming the major cause of renal failure in most societies
(>30% in our study), and these patients often have dia-
betic atherosclerosis of their radial arteries.20 In addition,
younger patients often receive transplants, leaving the
most difﬁcult patients for access formation. As a result,
FTM ﬁstulas or PFs due to JXA problems are a common
problem in our unit.
The conventional treatment of JXA segment problems
consists of endovascular angioplasty, surgical proximaliza-
tion, or creation of a new ﬁstula, usually at the cubital fossa.
All of these techniques have signiﬁcant limitations, as
described in the introduction.
We developed the JXAS technique to overcome the
above problems. The JXAS technique allows for preserva-
tion of ﬁstula length by avoiding proximalization of the ﬁs-
tula and the loss of ﬁstula access zone. Our technique also
allows rapid maturation of the FTM ﬁstula and immediate
restoration of dialysis in the failing PF.
The three principles of JXAS are (1) treatment of the
JXA segment as a unit; (2) the placement of JXAS using
uncovered nitinol stents; and (3) aggressive angioplasty
with rupture of the JXA segment.
Aggressive angioplasty with rupture of the JXA
segment stenoses can be performed because the stent pre-
serves the ﬁstula circuit continuity and hence preserves the
low pressures at which the ﬁstula operates. Fistula rupture,
both radiologic and clinical, is something we have per-
formed regularly during the last 10 years in native ﬁstula
circuits, and this can be done safely provided certain caveats
are followed. Early (minutes) and late (hours to days) recoil
are common after angioplasty alone, and we believe that
radiologic/clinical rupture of the stenosed segment of the
ﬁstula will prevent recoil.7,12,14
Our results with JXAS compare favorably with patency
rates reported in the literature. However, only a random-
ized trial of JXA angioplasty vs JXA angioplasty and stent-
ing can prove that the addition of a JXAS (and the
permissive aggressiveness of the angioplasty) is superior.To perform safe ﬁstula rupture, the following caveats
should be observed: Firstly, certain sites in the ﬁstula circuit
are safe to rupture, particularly the subcutaneous, venous
part of the ﬁstula circuit in the forearm, whereas rupture
in other sites can be dangerous (eg, a brachiocephalic
anastomosis).
Secondly, rupture is only safe if the ﬁstula has free and
unimpeded outﬂow to the right atrium from the point of
rupture to the heart. This assures a low pressure and
controlled rupture; hence, the importance of checking
the ﬁstula’s outﬂow on preoperative ultrasound imaging
and preprocedural outﬂow on contrast imaging.
Thirdly, rupture is best performed within the conﬁnes
of an uncovered nitinol stent; in itself, it does not prevent
extravasation but does guarantee continuity of the ﬁstula
circuit and, hence, low pressure ﬂow through the circuit.
Our series shows that JXA stenting of the RC AVF can
be done with a high technical success rate in experienced
hands and produces a durable medium-term result. It is
important to note that the ﬁstulas in our study are all
PFs, with about half of the study group ﬁstulas having
had interventions before the JXAS episode. A signiﬁcant
proportion of the immature ﬁstulas in the study would
have been abandoned or proximalized by our group in
the past. With the JXAS technique, we can bring these ﬁs-
tulas to maturity and maintain hemodialysis access at the
wrist in the short-term and medium-term. The use of un-
covered nitinol stents allows for endothelialization of the
stented part of the ﬁstula, and we have demonstrated this
on pathologic examination of explanted specimens.
Furthermore, puncture of certain types of nitinol stents is
still possible for hemodialysis.
JXAS of the RC AVF is a relatively safe procedure.
Ischemic problems with the hand have not occurred in
our current series, nor have we seen it in our much wider
experience in endovascular RC AVF interventions. Our
previous work on ﬁstula ultrasound imaging showed that
almost all radial arteries distal to the anastomosis demon-
strate reverse ﬂow; hence, steal or embolization is an un-
likely occurrence. The normal reverse ﬂow in the radial
artery means that in the presence of an RC AVF, hand
perfusion is not dependent on or contributed to by the
radial artery. We have not seen hand ischemic problems
in our series or experience with JXAS. In our ultrasound
follow-up of the JXAS, the outﬂow radial artery remains
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the stent interstices.
Sepsis in uncovered nitinol stents does not appear to be
a problem. In >1000 ﬁstula stents placed by our group,
and often needled repeatedly for hemodialysis access, we
have never had to remove a stent for reasons of sepsis.
Although recurrent stenosis occur within the JXAS
segment, these are not more common than those seen
with standard angioplasty and can be treated with endovas-
cular techniques as elsewhere in the ﬁstula circuit. The
advent of drug-eluting technology promises to improve
these results, and our early experience with drug-eluting
balloons has been positive.
We have used the JXAS technique sparingly in brachio-
cephalic and brachiobasilic ﬁstulas because of the signiﬁ-
cant dangers associated with intervention on the brachial
artery, including steal, embolization, and the possibility of
median nerve injury.
CONCLUSIONS
JXAS is a useful technique for ﬁxing nonmaturing or
failing RC ﬁstulas with good short- and medium-term
patency.
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